Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Neurotrophic/neuroprotective agents in development at Sanofi

Oct. 20, 1998

Good efficacy, tolerability reported for Almirall Prodesfarma's antimigraine candidate

Oct. 20, 1998

Statins provide protection against stroke via effects on eNOS

Oct. 20, 1998

Novel CNS technology with broad potential application available from BTG

Oct. 20, 1998

Clinical results cast further doubt on the role of substance P in migraine

Oct. 19, 1998

Verapamil recommended for first-line treatment of cluster headache

Oct. 19, 1998

Subtype-selective 5-HT1D agonists developed at MS&D for migraine

Oct. 19, 1998

Lundbeck describes novel class for psychiatric and neurological disorders

Oct. 19, 1998

CIMA completes study of Zomig using OraSolv technology

Oct. 19, 1998

Patent protection for method of treating neurodegenerative disorders pioneered by NeoTherapeutics

Oct. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...